If you use a continuous glucose monitoring (CGM) system, you usually have to remove the sensor before any imaging tests like ...
Continuous glucose monitors (CGMs) are monitoring devices people with diabetes use. They apply them directly to the skin and ...
FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...
First announced in August 2022, the 30,000-square metre facility will have the world’s highest production of sensors used in ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, ...
The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...
Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.
Opens in a new tab or window Abbott's FreeStyle Libre 2 and 3 are the first and only patient-applied continuous glucose monitoring (CGM) systems to be approved for use during medical imaging ...
--(BUSINESS WIRE)--Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce a ...
In a relatively short span, FreeStyle Libre has achieved global leadership among continuous glucose monitoring (CGM) systems for both Type 1 and Type 2 users. In the third quarter, in Diabetes ...